HIGHTIDE Trademark

Trademark Overview

On Sunday, July 22, 2018, a trademark application was filed for HIGHTIDE with the United States Patent and Trademark Office. The USPTO has given the HIGHTIDE trademark a serial number of 88047574. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 8, 2024. This trademark is owned by Shenzhen HighTide Biopharmaceutical, Ltd.. The HIGHTIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in treatment of diseases, namely, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and tumors; pharmaceutical preparations for use in treatment of hematological, diabetic, muscular, rheumatic, immunological, respiratory, central nervous system, bone, digestive, gastrointestinal, and liver diseases; pharmaceutical preparations for use in treatment of inflammatory bowel disease (IBD), namely, Crohn's disease and ulcerative colitis (UC); pharmaceutical preparations for use in treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
hightide

General Information

Serial Number88047574
Word MarkHIGHTIDE
Filing DateSunday, July 22, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements

Description of MarkThe mark consists of a circular design formed by three overlapping yet non-intersecting, curving bands, each in a varying shade of blue; the design is to the left and of the text "HIGHTIDE" in blue, the wording and design are all on a white background.
Goods and ServicesPharmaceutical preparations for use in treatment of diseases, namely, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and tumors; pharmaceutical preparations for use in treatment of hematological, diabetic, muscular, rheumatic, immunological, respiratory, central nervous system, bone, digestive, gastrointestinal, and liver diseases; pharmaceutical preparations for use in treatment of inflammatory bowel disease (IBD), namely, Crohn's disease and ulcerative colitis (UC); pharmaceutical preparations for use in treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
Pseudo MarkHIGH TIDE
Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 26, 2018
Primary Code005
First Use Anywhere DateSunday, July 22, 2018
First Use In Commerce DateFriday, November 12, 2021

Trademark Owner History

Party NameShenzhen HighTide Biopharmaceutical, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShenzhen, Guangdong 518112
CN
Party NameShenzhen HighTide Biopharmaceutical, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShenzhen, Guangdong 518112
CN

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 8, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, September 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 22, 2023NON-FINAL ACTION E-MAILED
Friday, September 22, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, September 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2023ASSIGNED TO LIE
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 1, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 25, 2023USE AMENDMENT FILED
Monday, May 1, 2023SOU EXTENSION 5 GRANTED
Tuesday, April 25, 2023SOU EXTENSION 5 FILED
Tuesday, April 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 25, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, October 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 7, 2022SOU EXTENSION 4 GRANTED
Friday, October 7, 2022SOU EXTENSION 4 FILED
Friday, October 7, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 2, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 3 FILED
Tuesday, May 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 4, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, May 3, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, May 3, 2022PETITION TO REVIVE-GRANTED
Tuesday, May 3, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, October 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 25, 2021SOU EXTENSION 2 GRANTED
Monday, October 25, 2021SOU EXTENSION 2 FILED
Monday, October 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021SOU EXTENSION 1 GRANTED
Friday, April 23, 2021SOU EXTENSION 1 FILED
Friday, April 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, July 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 10, 2020NON-FINAL ACTION E-MAILED
Friday, January 10, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION WRITTEN
Tuesday, June 4, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, June 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, May 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 10, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 10, 2018NON-FINAL ACTION E-MAILED
Saturday, November 10, 2018NON-FINAL ACTION WRITTEN
Thursday, November 8, 2018ASSIGNED TO EXAMINER
Friday, July 27, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 25, 2018NEW APPLICATION ENTERED

Related Keywords

hightide diseases pharmaceutical treatment preparations disease liver nonalcoholic namely nash inflammatory